EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer

Neslihan Cabioglu, Havva Belma Koçer, Hasan Karanlik, Mehmet Ali Gülçelik, Abdullah Igci, Mahmut Müslümanoglu, Cihan Uras, Baris Mantoglu, Didem Can Trabulus, Giray Akgül, Mustafa Tükenmez, Kazim Senol und 31 weitere

JAMA Surgery · 01.03.2025 · 160 (3) · 257

DOI: 10.1001/jamasurg.2024.5913 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA Surgery, erschienen am 01.03.2025. Verfasst von Neslihan Cabioglu und 42 weiteren Autor:innen. Beteiligte Einrichtung: Breast Unit, Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymph Node Excision, Lymph Nodes, Sentinel Lymph Node Biopsy. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Increasing evidence supports the oncologic safety of de-escalating axillary surgery for patients with breast cancer after neoadjuvant chemotherapy (NAC).

Objective

To evaluate the oncologic outcomes of de-escalating axillary surgery among patients with clinically node (cN)–positive breast cancer and patients whose disease became cN negative after NAC (ycN negative). Design, Setting, and Participants In the NEOSENTITURK MF-1803 prospective cohort registry trial, patients from 37 centers with cT1-4N1-3M0 disease treated with sentinel lymph node biopsy (SLNB) or targeted axillary dissection (TAD) alone or with ypN-negative or ypN-positive disease after NAC were recruited between February 15, 2019, and January 1, 2023, and evaluated. Exposure Treatment with SLNB or TAD after NAC. Main Outcomes and Measures The primary aim of the study was axillary, locoregional, or distant recurrence rates; disease-free survival; and disease-specific survival. Number of axillary lymph nodes removed was also evaluated.

Results

A total of 976 patients (median age, 46 years [range, 21-80 years]) with cT1-4N1-3M0 disease underwent SLNB (n = 620) or TAD alone (n = 356). Most of the cohort had a mapping procedure with blue dye alone (645 [66.1%]) with (n = 177) or without (n = 468) TAD. Overall, no difference was found between patients treated with TAD and patients treated with SLNB in the median number of total lymph nodes removed (TAD, 4 [3-6] vs SLNB, 4 [3-6]; P = .09). Among patients with ypN-positive disease, those who underwent TAD were more likely to have a lower median lymph node ratio (TAD, 0.28 [IQR, 0.20-0.40] vs SLNB, 0.33 [IQR, 0.20-0.50]; P = .03). At a median follow-up of 39 months (IQR, 29-48 months), no significant difference was found in the rates of ipsilateral axillary recurrence (0.3% [1 of 356] vs 0.3% [2 of 620]; P ≥ .99) or locoregional recurrence (0.6% [2 of 356] vs 1.1% [7 of 620]; P = .50) between the TAD and SLNB groups, with an overall locoregional recurrence rate of 0.9% (9 of 976). The initial clinical tumor stage, pathologic complete response, and use of blue dye alone as a mapping procedure were not associated with the outcome. Even though patients with TAD demonstrated an increased disease-free survival rate compared with the SLNB group, this difference did not reach statistical significance (94.9% vs 92.6%; P = .07). Factors associated with decreased 5-year disease-specific survival were cN2-3 axillary stage (cN1, 98.7% vs cN2-3, 96.8%; P = .03) and nonluminal type tumor pathologic characteristics (luminal, 98.9% vs nonluminal, 96.9%; P = .007). Conclusions and Relevance The short-term results suggest very low rates of axillary and locoregional recurrence in a select group of patients with cN-negative disease after NAC treated with TAD alone or SLNB alone followed by regional nodal irradiation regardless of the SLNB technique or nodal pathology. Whether TAD might provide a clear survival advantage compared with SLNB remains to be proven in studies with longer follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLymph Node ExcisionLymph NodesSentinel Lymph Node BiopsyAdultAgedAged, 80 and overFemaleHumansMiddle AgedYoung AdultAxillaLymphatic MetastasisNeoadjuvant TherapyNeoplasm Recurrence, LocalNeoplasm StagingProspective Studies

Autor:innen und Institutionen

  • Breast Unit, Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
  • Department of General Surgery, Sakarya University Faculty of Medicine, Sakarya, Türkiye.
  • Division of Surgical Oncology, Institute of Oncology, Istanbul University, Istanbul, Türkiye.
  • Division of Surgical Oncology, Health Sciences University Gulhane Faculty of Medicine, Ankara, Türkiye.
  • Department of General Surgery, American Hospital, Istanbul, Türkiye.
  • Department of General Surgery, School of Medicine, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Türkiye.

Zitieren

APA

Cabioglu, N., Koçer, H. B., Karanlik, H., Gülçelik, M. A., Igci, A., Müslümanoglu, M., Uras, C., Mantoglu, B., Trabulus, D. C., Akgül, G., Tükenmez, M., Senol, K., Özkurt, E., Sen, E., Karadeniz Çakmak, G., Bademler, S., Emiroglu, S., Yildirim, N., Kara, H., …, & Özmen, V. (2025). De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer. JAMA Surgery, 160(3), 257. https://doi.org/10.1001/jamasurg.2024.5913

Vancouver

Cabioglu N, Koçer HB, Karanlik H, Gülçelik MA, Igci A, Müslümanoglu M, et al. De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer. JAMA Surgery. 2025;160(3):257. doi:10.1001/jamasurg.2024.5913

BibTeX
@article{Cabioglu2025,
  author = {Cabioglu, Neslihan and Koçer, Havva Belma and Karanlik, Hasan and Gülçelik, Mehmet Ali and Igci, Abdullah and Müslümanoglu, Mahmut and Uras, Cihan and Mantoglu, Baris and Trabulus, Didem Can and Akgül, Giray and Tükenmez, Mustafa and Senol, Kazim and Özkurt, Enver and Sen, Ebru and Karadeniz Çakmak, Güldeniz and Bademler, Süleyman and Emiroglu, Selman and Yildirim, Nilüfer and Kara, Halil and Dag, Ahmet and Dilege, Ece and Altinok, Ayse and Basaran, Gül and Varol, Ecenur and Ugurlu, Ümit and Bölükbasi, Yasemin and Ersoy, Yeliz Emine and Zengel, Baha and Karaman, Niyazi and Özbas, Serdar and Zer, Leyla and Gül Kiliç, Halime and Agcaoglu, Orhan and Sakman, Gürhan and Utkan, Zafer and Soyder, Aykut and Akcan, Alper and Ergün, Sefa and Yilmaz, Ravza and Aydiner, Adnan and Soran, Atilla and Ibis, Kamuran and Özmen, Vahit},
  title = {De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer},
  journal = {JAMA Surgery},
  year = {2025},
  volume = {160},
  number = {3},
  pages = {257},
  doi = {10.1001/jamasurg.2024.5913}
}
Kostenlos starten →